IsoRay, Inc. (NYSE MKT: ISR), announced that IASIS Medical has received formal approval for the sale of IsoRay’s complete product line in Greece. IsoRay is a medical technology company and innovator in seed brachytherapy and medical radioisotope applications for brain cancer, lung cancer, head and neck cancer, prostate cancer and gynecologic (“gyn”) cancer. IsoRay, Inc. (NYSEMKT:ISR) shares after opening at $0.90 on last trade day and at the end of the day closed at $1.11. Company price to sales ratio in past twelve months was calculated as 9.27 and price to cash ratio as 9.69. IsoRay, Inc. (NYSEMKT:ISR) showed a negative weekly performance of 37.04%.
Tengion, Inc. (OTCMKTS:TNGN) said in a regulatory filing Thursday that its shareholders approved amending the company’s certificate of incorporation to allow it to increase the number of authorized shares of common stock from 750 million to 10 billion. Tengion, Inc. (OTCMKTS:TNGN) shares advanced 16.38% in last trading session and ended the day on $0.270. TNGN return on equity ratio is recorded as -71.90% and its return on assets is -56.60%. Tengion, Inc. (OTCMKTS:TNGN)yearly performance is 94.74%.
Hooper Holmes, Inc. (NYSEMKT:HH)is engaged in providing health risk assessment services to the life insurance and health industries Hooper Holmes operates in one business segment and provides paramedical and medical examinations, personal health interviews and record collection, and laboratory testing, which help life insurance companies evaluate the risks associated with underwriting policies. Hooper Holmes, Inc. (NYSEMKT:HH) shares moved up 8.77% in last trading session and was closed at $0.620, while trading in range of $0.57 – $0.65. Hooper Holmes, Inc. (NYSEMKT:HH) year to date (YTD) performance is 16.98%.
Ovascience Inc (NASDAQ:OVAS) major shareholder Fund L.P. Longwood bought 100,000 shares of the company’s stock on the open market in a transaction dated Friday, March 7th. The stock was purchased at an average cost of $10.00 per share, for a total transaction of $1,000,000.00. OvaScience Inc (NASDAQ:OVAS) weekly performance is 2.70%. On last trading day company shares ended up $10.26. OvaScience Inc (NASDAQ:OVAS) distance from 50-day simple moving average (SMA50) is 6.28%. Analysts mean target price for the company is $17.17.